Boonstra B, Rathbone D A, French C E, Walker E H, Bruce N C
Institute of Biotechnology, University of Cambridge, Cambridge CB2 1QT, United Kingdom.
Appl Environ Microbiol. 2000 Dec;66(12):5161-6. doi: 10.1128/AEM.66.12.5161-5166.2000.
We have applied the soluble pyridine nucleotide transhydrogenase of Pseudomonas fluorescens to a cell-free system for the regeneration of the nicotinamide cofactors NAD and NADP in the biological production of the important semisynthetic opiate drug hydromorphone. The original recombinant whole-cell system suffered from cofactor depletion resulting from the action of an NADP(+)-dependent morphine dehydrogenase and an NADH-dependent morphinone reductase. By applying a soluble pyridine nucleotide transhydrogenase, which can transfer reducing equivalents between NAD and NADP, we demonstrate with a cell-free system that efficient cofactor cycling in the presence of catalytic amounts of cofactors occurs, resulting in high yields of hydromorphone. The ratio of morphine dehydrogenase, morphinone reductase, and soluble pyridine nucleotide transhydrogenase is critical for diminishing the production of the unwanted by-product dihydromorphine and for optimum hydromorphone yields. Application of the soluble pyridine nucleotide transhydrogenase to the whole-cell system resulted in an improved biocatalyst with an extended lifetime. These results demonstrate the usefulness of the soluble pyridine nucleotide transhydrogenase and its wider application as a tool in metabolic engineering and biocatalysis.
我们已将荧光假单胞菌的可溶性吡啶核苷酸转氢酶应用于无细胞体系,用于在重要的半合成阿片类药物氢吗啡酮的生物生产中再生烟酰胺辅因子NAD和NADP。原始的重组全细胞体系因依赖NADP(+)的吗啡脱氢酶和依赖NADH的吗啡酮还原酶的作用而存在辅因子耗竭的问题。通过应用一种可在NAD和NADP之间转移还原当量的可溶性吡啶核苷酸转氢酶,我们在无细胞体系中证明,在存在催化量辅因子的情况下会发生高效的辅因子循环,从而产生高产率的氢吗啡酮。吗啡脱氢酶、吗啡酮还原酶和可溶性吡啶核苷酸转氢酶的比例对于减少不需要的副产物二氢吗啡的产生以及实现最佳氢吗啡酮产率至关重要。将可溶性吡啶核苷酸转氢酶应用于全细胞体系可得到一种寿命延长的改良生物催化剂。这些结果证明了可溶性吡啶核苷酸转氢酶的实用性及其作为代谢工程和生物催化工具的更广泛应用。